Aspect Partners’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.97K Hold
14
﹤0.01% 483
2026
Q1
$2.74K Hold
14
﹤0.01% 440
2025
Q4
$2.43K Buy
14
+3
+27% +$546 ﹤0.01% 494
2025
Q3
$2.1K Hold
11
﹤0.01% 526
2025
Q2
$1.98K Hold
11
﹤0.01% 474
2025
Q1
$1.86K Hold
11
﹤0.01% 456
2024
Q4
$1.66K Hold
11
﹤0.01% 490
2024
Q3
$1.71K Hold
11
﹤0.01% 454
2024
Q2
$1.51K Hold
11
﹤0.01% 477
2024
Q1
$1.46K Sell
11
-1
-8% -$130 ﹤0.01% 468
2023
Q4
$1.66K Buy
+12
New +$1.58K ﹤0.01% 450

Other funds holding DGX

Aspect Partners's DGX Position: Q2 2026 in Review

Aspect Partners held its Quest Diagnostics (DGX) position steady in Q2 2026 at 14 shares worth $2.97K. The position accounts for ﹤0.01% of the portfolio, ranked #483.

Aspect Partners first reported a position in DGX in Q4 2023 and has held it in 11 quarters since. 254 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Aspect Partners held 14 shares of Quest Diagnostics worth $2.97K as of Q2 2026.
  • Aspect Partners left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #483 holding.
  • Aspect Partners first reported a position in Quest Diagnostics in Q4 2023 and has held it in 11 quarters since.
  • 254 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.